Skip to content

Clinical trials

COVID-19 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Taiwan Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
202016
202113
202219
20239
20247
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status13
Recruiting8
Terminated4
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital16
Pfizer4
Chang Gung Memorial Hospital3
Gilead Sciences3
St. Martin De Porress Hospital3
United Biomedical Inc., Asia3
AstraZeneca2
Merck Sharp & Dohme LLC2
National Taiwan University2
Senhwa Biosciences, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1968
Coronavirus Infections7
Influenza, Human6
Post-Acute COVID-19 Syndrome4
Respiratory Tract Infections4
Anxiety Disorders3
Infections3
Lung Diseases3
Pneumonia3
Virus Diseases3

Trials

Showing 26 to 50 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.